Genetic diversity of the human immunodeficiency virus of type 1 in Gabonese transfusional settings

被引:3
|
作者
Mangala, Christian [1 ,2 ]
Fokam, Joseph [3 ]
Maulot-Bangola, Denis [1 ,2 ]
Rebienot-Pellegrin, Olivier [4 ]
Nkoa, Therese [1 ]
机构
[1] Catholic Univ Cent Africa CUCA, Yaounde, Cameroon
[2] Natl Publ Hlth Lab NPHL, Libreville, Gabon
[3] Chantal Biya Int Reference Ctr CBIRC, Yaounde, Cameroon
[4] Natl Blood Transfus Ctr NBTC, Libreville, Gabon
关键词
HIV-1; Genetic diversity; Residual risk; NBTC of Gabon; HEPATITIS-C VIRUS; BLOOD-TRANSFUSION; RESIDUAL RISK; TRANSMISSIBLE INFECTIONS; HIV; DONORS; HBV; HCV; PREVALENCE; REDUCTION;
D O I
10.1186/s12879-023-08154-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundThe high endemicity of transfusion-transmissible infections (TTIs) in sub-Saharan Africa is a real public health problem. To reduce the risk of HIV transmission through blood donation, the NBTC of Gabon has launched in recent years a reorganization of its blood transfusion system. This study aims to characterize the molecular strains of HIV-1 circulating in donors and to estimate the risk of viral transmission.Materials and methodsA cross-sectional study was carried out during the period from August 2020 to August 2021 among 381 donors who had agreed to donate blood at the National Blood Transfusion Center (NBTC). Viral load was determined by Abbott Real-Time (Abbott m2000 (R), Abbott) and sequencing by the Sanger method (ABI 3500 Hitachi (R)). The phylogenetic tree was constructed by MEGA X software. Data were checked, entered, and analyzed using SPSS version 21.0 software, with p <= 0.05 considered statistically significant.ResultsA total of 381 donors were enrolled in the study. Among the 359 seronegative donors, five (5) seronegative donors were detected positive for HIV-1 using Real-Time PCR. The residual risk was 648 per 1,000,000 donations. The prevalence of residual infection was 1.4% [0,01; 0,03]. Sixteen (16) samples were sequenced. The strains obtained were CRF02_AG (50%), subtype A1 (18.8%), subtype G (12.5%), CRF45_cpx (12.5%) and subtype F2 (6.2%). Six sequences clustered with A1, G, CRF02_AG, and CRF45_cpx subtypes.ConclusionThe residual risk of HIV-1 transmission by blood transfusion remains a concern in the Gabonese transfusional settings. A policy based on improving the current screening strategy would involve the implementation of the nucleic acid test (NAT) in order to optimize the safety of the donation by detecting the HIV-1 subtypes in circulation in the donors.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Human immunodeficiency virus type 1 Vpr increases hepatitis C virus RNA replication in cell culture
    Deng, Amei
    Chen, Chao
    Ishizaka, Yukihito
    Chen, Xinwen
    Sun, Binlian
    Yang, Rongge
    VIRUS RESEARCH, 2014, 184 : 93 - 102
  • [32] Human immunodeficiency virus type-1 group M quasispecies evolution: diversity and divergence in patients co-infected with active tuberculosis
    Biru, T.
    Lennemann, T.
    Stuermer, M.
    Stephan, C.
    Nisius, G.
    Cinatl, J.
    Staszewski, S.
    Guertler, L. G.
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2010, 199 (04) : 323 - 332
  • [33] Genetic diversity of human immunodeficiency viruses and antiretroviral therapy
    Bobkova, M. R.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (11) : 103 - 111
  • [34] Non-M Variants of Human Immunodeficiency Virus Type 1
    Mourez, Thomas
    Simon, Francois
    Plantier, Jean-Christophe
    CLINICAL MICROBIOLOGY REVIEWS, 2013, 26 (03) : 448 - 461
  • [35] Estimating window period blood donations for human immunodeficiency virus Type1, hepatitisC virus, and hepatitisB virus by nucleic acid amplification testing in Southern Pakistan
    Moiz, Bushra
    Moatter, Tariq
    Shaikh, Usman
    Adil, Salman
    Ali, Natasha
    Mahar, Farheen
    Shamsuddin, Naseem
    Khurshid, Mohammad
    TRANSFUSION, 2014, 54 (06) : 1652 - 1659
  • [36] Two years' experience of implementing molecular screening of hepatitis B virus, hepatitis C virus and human immunodeficiency virus 1, 2 in Riyadh blood donors
    Mohamud, Hanat S.
    Mohamed, Deqa H.
    Alqahtani, Farjah H.
    Almajid, Fahad M.
    Alswat, Khalid
    Somily, Ali M.
    TRANSFUSION AND APHERESIS SCIENCE, 2016, 54 (02) : 262 - 265
  • [37] First transmission of human immunodeficiency virus Type 1 by a cellular blood product after mandatory nucleic acid screening in Germany
    Schmidt, Michael
    Korn, Klaus
    Nuebling, C. Micha
    Chudy, Michael
    Kress, Julia
    Horst, Heinz A.
    Geusendam, Geert
    Hennig, Holger
    Sireis, Walid
    Rabenau, Holger F.
    Doerr, Hans Wilhelm
    Berger, Annemarie
    Hourfar, Michael Kai
    Gubbe, Knut
    Karl, Andreas
    Fickenscher, Helmut
    Tischer, B. Karsten
    Babiel, Reiner
    Seifried, Erhard
    Guertler, Lutz
    TRANSFUSION, 2009, 49 (09) : 1836 - 1844
  • [38] Human immunodeficiency virus type 1 impairs sumoylation
    Mete, Bilgul
    Pekbilir, Emre
    Bilge, Bilge Nur
    Georgiadou, Panagiota
    Celik, Elif
    Sutlu, Tolga
    Tabak, Fehmi
    Sahin, Umut
    LIFE SCIENCE ALLIANCE, 2022, 5 (06)
  • [39] Human immunodeficiency virus type 1 reverse transcriptase
    Hottiger, M
    Hubscher, U
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1996, 377 (02): : 97 - 120
  • [40] Defining the human immunodeficiency virus type 1 transmission genetic bottleneck in a region with multiple circulating subtypes and recombinant forms
    Nofemela, Andile
    Bandawe, Gama
    Thebus, Ruwayhida
    Marais, Jinny
    Wood, Natasha
    Hoffmann, Oliver
    Maboko, Leonard
    Hoelscher, Michael
    Woodman, Zenda
    Williamson, Carolyn
    VIROLOGY, 2011, 415 (02) : 107 - 113